Telix Pharmaceuticals TLX
NASDAQ TLX
$11.34 -0.28 (-2.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Enterprise Value (2024 - 2026)

Updated

Telix Pharmaceuticals' Enterprise Value was $3.61 billion in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Enterprise Value (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Telix Pharmaceuticals' Enterprise Value was $2.85 billion through Jun 30, 2026; for the year ended Dec 31, 2025, it was $2.36 billion, down 49.3% from the prior year.

  • In earlier years, Enterprise Value was $4.65 billion in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Enterprise Value since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Telix Pharmaceuticals 3.94 Bn 2.88 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.61 Bn
Dec 31, 2025 2.36 Bn
Dec 31, 2024 4.65 Bn
API Access

Telix Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=TLX&period=max&api_key=YOUR_API_KEY